Current location: Home
Welcome to UROPAC.ORG!

Only personal contributions to UROPAC can be used for federal campaigns. Corporate contributions to UROPAC can only be used for administrative costs. If you have any further questions please do not hesitate to contact us at info@uropac.org

It’s Time to Head to Washington!

Join the American Association of Clinical Urologists and the American Urological Association in Washington, DC, March 4-6, 2012, and let your voice be heard on Capitol Hill!

Register Today

The AACU and AUA are pleased to announce that Michael LeFevre, MD, MSPH, co-Vice Chair of the U.S. Preventative Services Task Force will take part in the 2012 Urology Joint Advocacy Conference, scheduled for March 4-6 in Washington, DC.

As co-Vice Chair of the USPSTF, Dr. LeFevre played a key role in drafting that panel's recommendation against PSA-based screening for prostate cancer for all men, at all ages. Dr. LeFevre will address the conference and invite questions from urologists about the USPSTF and its growing influence.

Your AACU and AUA membership grants you access to this highly-anticipated conference, but attendance numbers are quickly growing, so Register Online Today.

The 2012 Urology Joint Advocacy Conference will springboard from Dr. LeFevre's presentation to consider grassroots mobilization campaigns and "lessons learned" from representatives of the Susan G. Komen Breast Cancer Foundation.

Additional featured speakers include AACU Russell Carson Memorial Lecturer Rep. Tom Price, MD (R-GA), a member of the conference committee tasked with the latest SGR fix and Charlie Cook, noted political columnist and prognosticator.

Needless to say, this election-year event is vital for the entire urologic community.


DONATE TO UROPAC TODAY!



As national healthcare reform moves forward at a frantic pace, it may be very detrimental to urology. There is no time to waste; UROPAC needs your financial support now more than ever.

A major battle in urology’s fight is Congress’ attempt to limit your access to in-office ultrasound. Ultrasound is a key diagnostic tool for specialists much like the stethoscope is for primary care physicians. Congress is attempting to expand the Medicare Payment Advisory Commission’s (MedPAC) recommendation meant to apply only to advanced, expensive imaging such as CT, MRI and PET scans to more cost-effective imaging such as ultrasound. They are also seeking to expand the Medicare Improvements for Patients and Providers Act (MIPPA) accreditation requirement to ultrasound…Read More

UROPAC Honor Roll

UROPAC thanks its Capitol Club ($1000+), Congressional Benefactor ($535+), and UROPAC Member ($250+) members for their generous contributions.

These contributions allow urology to speak with one voice to elected officials, and expands your influence beyond your individual legislative district. We will continue our fight in this critical year even more aggressively than ever.


Update on Supreme Court Campaign Finance Decision:

In January, the Supreme Court ruled in a 5-4 vote to end a 20-year-old limit on corporate and union influence on Presidential and Congressional campaigns. Corporations and unions had been prohibited for decades from spending money from their general treasuries aimed at electing or defeating candidates. The ruling now allows corporations to spend general treasury funds freely to support or oppose campaigns and candidacies.  The decision, however, left in place the prohibition on direct contributions from corporations and unions to candidates. Many are bracing for a dramatic increase in political spending.

The ruling does not impact UROPAC or other political action committees (PACs) that set limits on the amount individuals may contribute to a candidate. PAC funding is composed of voluntary donations from individuals and employees of a corporation or union, but not from a corporation or union’s treasuries. To be clear, urologists are encouraged to give their personal funds to UROPAC, rather than corporate/LLC funds, which cannot be distributed to regulated federal campaign finance entities.